BBS-Bioactive Bone Substitutes Oyj (BONEH) — Strategic Asset Allocation Index
BBS-Bioactive Bone Substitutes Oyj (BONEH) has a Strategic Asset Allocation Index of 21.6% as of June 2023. Strategic assets (PP&E of €942.00K plus long-term investments of €-) total €942.00K, measured against net assets of €4.36 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check BONEH financial resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
BBS-Bioactive Bone Substitutes Oyj Strategic Asset Allocation Index (2017–2022)
This chart shows how BBS-Bioactive Bone Substitutes Oyj's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 21.6%, representing strategic assets of €942.00K against net assets of €4.36 Million EUR. See BBS-Bioactive Bone Substitutes Oyj free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for BBS-Bioactive Bone Substitutes Oyj (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for BBS-Bioactive Bone Substitutes Oyj from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see BBS-Bioactive Bone Substitutes Oyj (BONEH) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 24.0% | €1.02 Million | €1.02 Million | €- | €4.27 Million | ▼ -7.6 pp |
| 2021 | 31.6% | €1.15 Million | €1.15 Million | €- | €3.63 Million | ▲ +11.8 pp |
| 2020 | 19.8% | €1.20 Million | €1.20 Million | €- | €6.09 Million | ▼ -21.9 pp |
| 2019 | 41.7% | €1.28 Million | €1.28 Million | €- | €3.08 Million | ▲ +9.7 pp |
| 2018 | 32.0% | €1.41 Million | €1.41 Million | €- | €4.42 Million | ▼ -109.9 pp |
| 2017 | 141.8% | €1.53 Million | €1.53 Million | €- | €1.08 Million | — |